US OptionsDetailed Quotes
LEGN250117P55000
- 5.80
- 0.000.00%
15min DelayClose Dec 26 16:00 ET
0.00High0.00Low
5.80Open5.80Pre Close0 Volume8 Open Interest55.00Strike Price0.00Turnover0.00%IV-50.09%PremiumJan 17, 2025Expiry Date22.22Intrinsic Value100Multiplier22DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.49Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Legend Biotech Stock Discussion
Sign in to post a comment
$General Motors (GM.US)$
$Philip Morris International (PM.US)$
$Tilray Brands (TLRY.US)$
$iQIYI (IQ.US)$
$Trump Media & Technology (DJT.US)$
$Joby Aviation (JOBY.US)$
$ZEEKR (ZK.US)$
$Core Scientific (CORZ.US)$
$TAL Education (TAL.US)$
$COUNTRY GARDEN HLD (Delisted) (CTRYY.US)$
$JinkoSolar (JKS.US)$
$MINISO (MNSO.US)$
$Pan American Silver (PAAS.US)$
$DiDi Global Inc (DIDIY.US)$
$First Majestic Silver (AG.US)$
$Legend Biotech (LEGN.US)$
$Li Auto (LI.US)$
$GigaCloud Technology (GCT.US)$
$PDD Holdings (PDD.US)$
...
$Philip Morris International (PM.US)$
$Tilray Brands (TLRY.US)$
$iQIYI (IQ.US)$
$Trump Media & Technology (DJT.US)$
$Joby Aviation (JOBY.US)$
$ZEEKR (ZK.US)$
$Core Scientific (CORZ.US)$
$TAL Education (TAL.US)$
$COUNTRY GARDEN HLD (Delisted) (CTRYY.US)$
$JinkoSolar (JKS.US)$
$MINISO (MNSO.US)$
$Pan American Silver (PAAS.US)$
$DiDi Global Inc (DIDIY.US)$
$First Majestic Silver (AG.US)$
$Legend Biotech (LEGN.US)$
$Li Auto (LI.US)$
$GigaCloud Technology (GCT.US)$
$PDD Holdings (PDD.US)$
...
12
2
» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$
...
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$
...
8
3
🗓️ Last week’s PDUFAs:
$Supernus Pharmaceuticals (SUPN.US)$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$Legend Biotech (LEGN.US)$ & $Johnson & Johnson (JNJ.US)$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$AstraZeneca (AZN.US)$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio (TSVT.US)$ & $Bristol-Myers Squibb (BMY.US)$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$Vanda Pharmaceuticals (VNDA.US)$...
$Supernus Pharmaceuticals (SUPN.US)$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$Legend Biotech (LEGN.US)$ & $Johnson & Johnson (JNJ.US)$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$AstraZeneca (AZN.US)$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio (TSVT.US)$ & $Bristol-Myers Squibb (BMY.US)$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$Vanda Pharmaceuticals (VNDA.US)$...
11
2
1
$Legend Biotech (LEGN.US)$
waiting patiently for fda 😌🙏✨
waiting patiently for fda 😌🙏✨
1
🗓️ Last week’s PDUFAs:
$Akebia Therapeutics (AKBA.US)$ : Approved 🎉
⇒ Vafseo (Vadadustat)
⇒ Anemia due to CKD
⇒ NDA
⇒ PDUFA: 3/27/24
$Merck & Co (MRK.US)$ : Approved 🎉
⇒ WINREVAIR (sotatercept)
⇒ Pulmonary arterial hypertension
⇒ BLA
⇒ PDUFA: 3/26/24
$AstraZeneca (AZN.US)$ : Approved 🎉
⇒ Ultomiris (ravulizumab)
⇒ NMOSD
⇒ sBLA
$Regeneron Pharmaceuticals (REGN.US)$ : CRL 🙁
⇒ Odronextamab
⇒ r/r FL and r/r DLBCL
⇒ BLA
⇒ PDUFA: 3/31/24
📌 This week’s PDUFAs: 🚨
$AstraZeneca (AZN.US)$ : 🤔
⇒...
$Akebia Therapeutics (AKBA.US)$ : Approved 🎉
⇒ Vafseo (Vadadustat)
⇒ Anemia due to CKD
⇒ NDA
⇒ PDUFA: 3/27/24
$Merck & Co (MRK.US)$ : Approved 🎉
⇒ WINREVAIR (sotatercept)
⇒ Pulmonary arterial hypertension
⇒ BLA
⇒ PDUFA: 3/26/24
$AstraZeneca (AZN.US)$ : Approved 🎉
⇒ Ultomiris (ravulizumab)
⇒ NMOSD
⇒ sBLA
$Regeneron Pharmaceuticals (REGN.US)$ : CRL 🙁
⇒ Odronextamab
⇒ r/r FL and r/r DLBCL
⇒ BLA
⇒ PDUFA: 3/31/24
📌 This week’s PDUFAs: 🚨
$AstraZeneca (AZN.US)$ : 🤔
⇒...
10
4
The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$Vanda Pharmaceuticals (VNDA.US)$ $Legend Biotech (LEGN.US)$ $Supernus Pharmaceuticals (SUPN.US)$ $ImmunityBio (IBRX.US)$ $Aquestive Therapeutics (AQST.US)$ $X4 Pharmaceuticals (XFOR.US)$ $Liquidia (LQDA.US)$ $Neurocrine Biosciences (NBIX.US)$ $Moderna (MRNA.US)$ $Day One Biopharmaceuticals (DAWN.US)$
...
$Vanda Pharmaceuticals (VNDA.US)$ $Legend Biotech (LEGN.US)$ $Supernus Pharmaceuticals (SUPN.US)$ $ImmunityBio (IBRX.US)$ $Aquestive Therapeutics (AQST.US)$ $X4 Pharmaceuticals (XFOR.US)$ $Liquidia (LQDA.US)$ $Neurocrine Biosciences (NBIX.US)$ $Moderna (MRNA.US)$ $Day One Biopharmaceuticals (DAWN.US)$
...
21
2
3
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Legend Biotech (LEGN.US)$ $Johnson & Johnson (JNJ.US)$
⇨ FDA’s briefing docs released today! 🔔
⚠️ Early deaths in cilta-cel arm raise FDA concern despite PFS benefit... 🤔
$LEGN trending up ~6% after doc release 📈
ℹ️ CARVYKTI (ciltacabtagene autoleucel)
⇒ multiple myeloma
⇒ CARTITUDE-4 study
⇒ sBLA
⇒ PDUFA: 4/5/24
❓AdCom Discussion & Question:
Discussion Topic:
⇒ Discuss whether the results of CARTITUDE-4 provided in the supplemental application are sufficient to support a positive...
⇨ FDA’s briefing docs released today! 🔔
⚠️ Early deaths in cilta-cel arm raise FDA concern despite PFS benefit... 🤔
$LEGN trending up ~6% after doc release 📈
ℹ️ CARVYKTI (ciltacabtagene autoleucel)
⇒ multiple myeloma
⇒ CARTITUDE-4 study
⇒ sBLA
⇒ PDUFA: 4/5/24
❓AdCom Discussion & Question:
Discussion Topic:
⇒ Discuss whether the results of CARTITUDE-4 provided in the supplemental application are sufficient to support a positive...
3
2
Before the Open: LEGN (-.32)After the Close: CASY (2.14), ORCL (1.38)
1
The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$Eyenovia (EYEN.US)$ $Vanda Pharmaceuticals (VNDA.US)$ $Mirum Pharmaceuticals (MIRM.US)$ $Madrigal Pharmaceuticals (MDGL.US)$ $Geron (GERN.US)$ $Bristol-Myers Squibb (BMY.US)$ $2seventy bio (TSVT.US)$ $Legend Biotech (LEGN.US)$ $OptiNose (OPTN.US)$ $Orchard Therapeutics (ORTX.US)$ $Merck & Co (MRK.US)$ $Akebia Therapeutics (AKBA.US)$ $AstraZeneca (AZN.US)$ $Liquidia (LQDA.US)$ $Esperion Therapeutics (ESPR.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $BeiGene (BGNE.US)$
$Eyenovia (EYEN.US)$ $Vanda Pharmaceuticals (VNDA.US)$ $Mirum Pharmaceuticals (MIRM.US)$ $Madrigal Pharmaceuticals (MDGL.US)$ $Geron (GERN.US)$ $Bristol-Myers Squibb (BMY.US)$ $2seventy bio (TSVT.US)$ $Legend Biotech (LEGN.US)$ $OptiNose (OPTN.US)$ $Orchard Therapeutics (ORTX.US)$ $Merck & Co (MRK.US)$ $Akebia Therapeutics (AKBA.US)$ $AstraZeneca (AZN.US)$ $Liquidia (LQDA.US)$ $Esperion Therapeutics (ESPR.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $BeiGene (BGNE.US)$
21
No comment yet
廣理右汛 : Support. Sending you a block.
adaptable Otter_3218 : Ag